highlighting Patient Expert Engagement Resource (PEER) and featuring quotes and
footage from Bristol-Myers Squibb (BMS) leadership and several advocate partners.
exciting shift in our company mindset and will help ensure we have appropriate
patient advocate insights at every step of our drug discovery and development
process as we work to achieve our mission of transforming patients’ lives
through science.
A Groundbreaking Effort to Bring the Patient Voice into All We Do
Patient Expert Engagement Resource (PEER) amplifies patient voices across Bristol Myers Squibb
SEPTEMBER 14, 2020
When asked why it is critical to bring the patient voice into drug discovery and development, Andrea Vassalotti, director, partnerships and programmes at World Heart Federation, cited a sobering statistic: Research has shown that only half to two-thirds of cardiovascular patients actually take medication in the way it was prescribed by their physician.
“Some medications can cause side effects that prevent patients from following their prescribed regimen,” said Vassalotti. “These insights often motivate industry to advance therapeutic options that don’t cause the same concerns, which can have a positive influence on adherence. It’s essential for the industry to see beyond just clinical data to explore the true impact medications have on patient quality of life.”
Weaving the patient perspective into the development and commercialization of medicines has become increasingly important industry-wide, particularly at Bristol Myers Squibb. For the past year, the company has worked closely with expert patient advocates to define and implement an innovative new process spanning all markets and therapeutic areas: Patient Expert Engagement Resource, or PEER.